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What’s already known about this topic? 
 Skin cancer is the most common malignancy worldwide. 
 Patients frequently present to general practitioners (GPs) with skin lesions they are 
concerned about. 
 They often exert pressure on their GPs to excise lesions. 
 
What does this study add? 
 Nearly two-thirds of lesions excised in primary care are for skin cancer. 
 After adjusting for surface area the density of malignant and pre-malignant skin lesions is 
highest on the more chronically sun exposed body sites. 
 Women and younger patients are significantly more likely to exert pressure to excise a 
benign pigmented lesion. 
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Abstract 
 
Background: Concern about skin cancer is a common reason for people from predominantly fair-
skinned populations present to primary care doctors.  
Objectives: To examine the frequency and body site distribution of malignant, pre-malignant and 
benign pigmented skin lesions excised in primary care.   
Methods: This prospective study conducted in Queensland, Australia, included 154 primary care 
doctors. For all excised or biopsied lesions, doctors recorded the patient’s age and sex, body site, 
level of patient pressure to excise, and the clinical diagnosis. Histological confirmation was 
obtained through pathology laboratories. 
Results: Of 9,650 skin lesions, 57.7% were excised in men and 75.0% excised in patients ≥ 50 
years. The most common diagnoses were basal cell carcinoma (BCC) (35.1%) and squamous cell 
carcinoma (SCC) (19.7%).  Compared to the whole body, highest densities for SCC, BCC and 
actinic keratoses were observed on chronically sun exposed areas of the body including the face in 
men and women, the scalp and ears in men, and the hands in women. The density of BCC was also 
high on intermittently or rarely exposed body sites. Women, younger patients and patients with 
melanocytic naevi were significantly more likely to exert moderate/high levels of pressure on the 
doctor to excise.  
Conclusions: More than half excised lesions were skin cancer which mostly occurred on the more 
chronically sun exposed areas of the body. Information on the type and body site distribution of 
skin lesions can aid in diagnosis and planned management of skin cancer and other skin lesions 
commonly presented in primary care.  
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Introduction 
Skin cancer is the most common malignancy in fair-skinned populations around the world.  It is 
estimated that 434,000 people were diagnosed with non-melanoma skin cancer (NMSC) in 2008 in 
Australia, 
1
 and nearly 84,500 individuals were diagnosed with NMSC in 2007 in the United 
Kingdom (UK). 
2
 Rates of NMSC and melanoma continue to rise in countries with predominantly 
fair-skinned populations. 
3
 
 
The diagnosis and management of common skin lesions represents a significant workload for 
General Practitioners (GPs). The UK has a similar two-tiered health service system to Australia, 
whereby the GP is the initial point of contact for most patients. In Australia, GPs bill for patient 
consultations and procedures through a universal health insurance scheme (Medicare), while GPs in 
the UK work under national health service contracts (General Medical Services Contract) 
4
  linked 
to payments.  
 
Unlike specialist settings where patients are usually referred following an initial consultation in 
primary care, patients commonly present to GPs with a diverse range of skin lesions.  In Australia 
about half of excised lesions are NMSC. 
5,6
 Other common diagnoses include actinic (solar) 
keratoses, thought to be a form of in situ SCC which in some cases can develop into invasive SCC, 
7,8
 and benign pigmented lesions such as melanocytic and dysplastic naevi and seborrhoeic 
keratosis. 
9
 Overall about 90% of pigmented lesions seen in general practice are melanocytic naevi. 
9-11
 
 
An understanding of patterns and the distribution of skin lesions can provide aetiological clues and 
may help inform possible diagnosis and appropriate management. Previous studies examining body 
site distribution of common skin lesions have primarily relied on retrospective data obtained 
through pathology services and/or extraction of data from medical records. 
12,13
 In contrast the 
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present study was conducted prospectively in primary care surgeries, thus reflecting typical day-to-
day clinical practice presentations.  
 
The aim of this study was to examine and report on the frequency and body site distribution of 
common skin lesions presenting to, and excised in, primary care following a skin examination, the 
degree of pressure by patients to excise, and factors that influence patient pressure to excise a 
lesion.  
 
Materials and Methods 
The study methodology has been described in detail previously. 
6
 Briefly, the study included 154 
primary care doctors located in South-East Queensland, Australia. Participating doctors recorded 
the details of all consultations involving a skin examination over a specified time period including: 
patient’s age and sex; type of skin examination (whole-body, part-body, specific lesions); and who 
initiated the examination (doctor, patient as primary reason for consultation or patient as the 
secondary reason for consultation). For excised or biopsied lesions, doctors also recorded the body 
site; degree of patient pressure to excise (on a scale of 1 to 5 with 1 being 'no pressure' and 5 being 
'pressure was only reason for excision'); and the clinical diagnosis.  Trained research personnel 
extracted information from histopathology reports including body site and histological diagnosis. 
Diagnoses were grouped into eight major categories including: melanoma (including Hutchinson’s 
Melanotic Freckle);  squamous cell carcinoma (SCC) (including keratoacanthoma and Bowen’s 
disease); basal cell carcinoma (BCC); actinic keratosis; dysplastic naevi; melanocytic naevi; other 
benign pigmented lesions (such as seborrhoeic keratosis, lentigo, lichenoid keratosis); and other 
benign non-pigmented lesions (cysts, warts, skin tags). Due to the variety of diagnoses for other 
benign non-pigmented lesions it was not possible to appropriately combine them into one category, 
so they were excluded from this analysis (n=1,771 [15.5%]). Where a lesion was given multiple 
diagnoses a malignant diagnosis was selected as the primary diagnosis.  
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Ethical approval was obtained from the Behavioural and Social Sciences Ethical Review Committee 
of the University of Queensland. 
 
Analysis 
The analysis included only those lesions for which information was available on exact body site, 
age, sex and histology (n=9,650 [(96.8%]). Body-sites were categorised as: scalp; face; ear; neck; 
upper arm/shoulders; forearm; hand; chest/abdomen; back; buttocks; thigh; lower leg and foot. 
Logistic regression analyses were used to examine differences in the frequency distributions of 
histological diagnosis by sex and age group (< 50 and ≥ 50 years) and to examine differences in the 
body site distribution for each histological type by sex and age group with analyses adjusted for 
clustering by doctor and patient. To account for surface area of the skin at each body site relative to 
the whole body, relative tumour densities (RTD) were calculated by dividing the proportion of 
lesions at a specific site by the average proportion of skin surface area at that site using the formula 
suggested by Pearle 
14
 and the estimated proportion of surface area suggested by Lund and 
Browder. 
15
 For example according to Lund and Browder the back is equivalent to 13% of the body 
thus if 48 of 152 melanomas occurred on the back then the RTD of melanoma on the back= 
(48/152)/0.13=2.43. RTD’s were transformed and graphed using a log scale to better reflect the 
differences in densities compared to the overall body density of 1. Body sites with no lesions were 
not graphed. Logistic regression analysis was used to analyse factors related to moderate to high 
levels of pressure to excise benign pigmented lesions. Variables that showed significant bivariate 
associations or were known or suspected confounders were included in the model.  A stepwise 
selection approach was implemented based on the likelihood ratio of each successive model, and a 
significance level of 0.05 was used for the final model and was adjusted for clustering of patients 
and doctors. All analyses were performed using Stata Statistical Software, version 10.1 (Statacorp 
LP, College Station, Tex).   
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Results 
Of 9,650 lesions excised in 7,133 patients, 57.7% were excised in men and 75.0% excised in 
patients 50 years and over. The most common diagnoses were BCC (35.1%), SCC (17.7%) and 
actinic keratoses (14.8%). Just under 11% were melanocytic naevi, 6.2% were dysplastic naevi and 
1.6% were melanoma (Table 1).  
 
BCC was more common in men (39.4% of lesions) than women (29.3%), (p < 0.001). Nearly 14% 
of lesions excised in women were melanocytic naevi compared to 8.2% in men (p < 0.001). Nearly 
two-thirds (63.1%) of excised lesions in patients ≥ 50 years were malignant (melanoma, SCC or 
BCC) compared to just over one-third (36.1%) for those < 50 years (p < 0.001). Melanocytic lesions 
were more commonly excised in younger patients (30.6% of all lesions) compared to older patients 
(p < 0.001) (Table 1).  
 
Distribution of histological diagnoses by gender and age group according to body site  
Melanoma was more frequently diagnosed on the back and upper arm in men (37.0% and 21.0%, 
respectively) and on the upper arm, back and lower legs in women (23.1%, 21.1% and 17.3%, 
respectively) (Table 2). SCC was more commonly excised on the face in both men and women 
(23.2% and 27.0%, respectively), however men had significantly more SCCs excised from the scalp 
and ears (p < 0.001). The body site distribution of dysplastic and melanocytic naevi was similar to 
that for melanoma with most lesions excised from the back for both men and women. Women had 
more benign pigmented lesions excised from the face and men had more lesions excised from the 
back (p=0.02).   
 
Melanoma was almost twice as prevalent on the forearm in those aged < 50 years compared to 
patients ≥ 50 years (16.7% and 8.7% respectively). SCC was more commonly excised on the face in 
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both age groups, followed by the hand (16.9%) and forearm (15.6%) for patients < 50 years, and the 
lower leg (21.6%) and forearm (13.7%) for patients ≥ 50 years. More than half of dysplastic naevi 
were excised from the back for both age groups. Younger patients had significantly more 
melanocytic naevi excised from their chest/abdomen than older patients (16.9% and 8.0%, 
respectively) (Table 3).  
 
 Adjusting for surface area 
Figs 1 and 2 illustrate the relative tumour density (RTD) of malignant and pre malignant lesions, 
and the most common benign pigmented lesions excised or biopsied for men and women and by age 
group according to body site plotted on a log scale.  
 
Malignant and pre-malignant lesions excised in males and females 
In men, the density of melanoma was five times as high on the face and four times as high on the 
ears compared to the body as a whole (RTD=5.0 and 4.0, respectively) and nearly three times 
higher for sites such as the neck, upper arm/shoulders and back (Fig1).  For BCC, SCC and actinic 
keratosis the density of lesions was 12 to 15 times higher on the face and ears compared to the 
whole body. The RTD for BCC on the upper arm/shoulder (1.6) and the back (1.9) were more than 
double that observed for SCCs at the same sites (0.4 and 0.9 respectively). However the density of 
malignant and pre-malignant lesions was very low on sites such as the chest/abdomen and thigh.   
 
In women, the density of excised melanoma was four times higher on the face and three times 
higher on the neck and upper arm/shoulders compared to the whole body.  For SCC, BCC and 
actinic keratosis the density of lesions was 11 to 17 times higher on the face compared to the whole 
body (11.3; 12.8 and 17.5, respectively). High relative densities of SCC and actinic keratosis were 
observed on the hands (2.2 and 2.3, respectively). The density of lesions was low for the 
chest/abdomen and the thigh.  
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Benign pigmented lesions excised in males and females 
In men, the density of dysplastic naevi was over four times higher on the back (4.3) compared to the 
whole body. The RTD of melanocytic naevi excised from the face was 4.9, 3.5 for the ears and 3.0 
for the back. For benign pigmented lesions, extremely high RTDs were observed on chronically sun 
exposed sites such as the face (7.7), ears (5.7) and neck (2.6). For women, the density of dysplastic 
naevi was nearly four times higher on the back (3.7) compared to the whole body. The highest 
density of melanocytic naevi were observed on the face (5.5) and ear (3.5). The density of benign 
pigmented lesions was over 10 times higher on the face than the whole body, whereas these lesions 
were only rarely excised from the lower body.  
 
Malignant and pre-malignant lesions by age group 
In patients < 50 years the density of excised melanoma was highest on the face (RTD=3.4), upper 
arm/shoulders (3.0) and back (2.7) compared to the body as a whole. For SCC, BCC and actinic 
keratosis RTD’s were nine to 15 times higher on the face. The RTD of SCC and actinic keratosis 
were three times higher on the hand (3.4 and 3.3, respectively) compared to the whole body. For 
patients 50 years or more, the RTD of excised melanoma was highest on the face (5.1) and then the 
ears (3.5) and neck (3.3). The RTD’s for SCC, BCC and actinic keratosis were all nine to 12 times 
higher for the more chronically exposed body-sites such as the face and ear (Fig 2).    
 
Benign pigmented lesions by age group 
Compared to the body as a whole, the density of dysplastic naevi were more than four times higher 
on the back for both younger and older patients (Figure 4). For younger patients the RTD of excised 
melanocytic naevi was three to four times higher on the face (4.3) and ears (3.5) and more than 
twice as high on the back (2.4).   In older patients, the density of excised melanocytic naevi and 
other benign pigmented lesions was seven to eight times higher on the face and three to four times 
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higher on the ears compared to the body as a whole. The density of benign pigmented lesions was 
low for sites such as the thigh and lower leg in both age groups.   
 
Pressure from the patient to excise or biopsy skin lesions 
We examined the degree of patient pressure to excise benign pigmented lesions (n=2,644). Overall, 
just over one-third (36.4%) of patients exerted a moderate to high degree of pressure on the doctor 
to excise a skin lesion and this was more common in women. Moderate to high pressure to excise 
was recorded for nearly 50% of benign pigmented lesions on the head and neck compared to 29% 
of lesions on the lower limbs. In multivariate analysis, factors positively associated with a moderate 
to high degree of pressure to excise included being female, being aged 30 to 49 years, having a 
lesion on the head or neck, having a melanocytic naevus and undergoing a part-body examination or 
a check of specific lesions (Table 4).  
 
Discussion 
This study examined the site and histological distribution of skin lesions excised or biopsied in 
primary care practice.  Nearly two-thirds of lesions were malignant or pre-malignant. BCC 
accounted for over one-third and nearly two-thirds of all skin cancer diagnoses. The ratio of BCC to 
SCC was about 2 to 1 and this is in keeping with other studies in high incidence populations.
13,16
 In 
populations at higher latitudes and lower risk, the occurrence of BCC can be up to five-fold higher 
than SCC. 
12,17
 Excision of any type of skin cancer was approximately 40% more common in men 
than women (M:F ratio=1:0.6) and about 80% more common in patients over the age of 50 years 
compared to younger patients.   
 
Compared to the whole body, five sites in men had a higher than average density of melanoma 
(ears, face, neck, back, upper arm/shoulders) and six sites in women (face, neck, upper 
arm/shoulders, forearm, back and lower legs). Although our findings are based on a relatively small 
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number of melanomas (n=152), they are consistent with other published studies.  
18
 There is now 
growing evidence that the relationship between melanoma and patterns of sun exposure varies 
according to age, site, and morphology. For example, melanoma that occurs on more chronically 
sun exposed sites such as the face, and head and neck region is more likely to be associated with 
older age as we have found in this study, while melanoma occurring on intermittently exposed sites 
such as the trunk and upper limbs is more likely to be associated with onset at an earlier age. 
19
  
 
The relative densities of BCC and SCC for the more chronically sun exposed sites such as face, ears 
and scalp (in men) were high and followed a similar pattern to that reported in other studies both in 
high and low risk populations. 
12,14,16,20
Skin lesions excised on other chronically sun exposed sites 
such as the forearm and hand were significantly more likely to be SCC or actinic keratosis than 
BCC. Interestingly men were around 30% less likely to have such a lesion excised from their hand 
compared to women. A similar differential was found for the lower leg, with men around 20% less 
likely to have a lesion excised from the lower leg compared to women.  
 
The density of actinic keratosis followed a similar pattern to SCC. This is not surprising given that 
actinic keratosis is considered by some to be a precursor to SCC, or at the very least a risk factor.
21
 
Studies have reported 60% of incidental SCCs developed from an existing actinic keratosis, 
22
 while 
others report nearly three-quarters of SCCs were contiguous with an actinic keratotic lesion.
23
  
 
Excisions or biopsy of benign pigmented lesions accounted for more than one-third of all lesions in 
this population group with melanocytic naevus accounting for the majority. Compared to the body 
as a whole, the density of excised melanocytic naevi followed a similar distribution to that of 
melanoma and was highest on the face in both men and women.   This is likely to reflect both the 
known correlation between the development of melanocytic naevi and sun exposure, and the ready 
visibility to the patient of any apparent changes.  
24,25
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Consistent with this, patient pressure to excise benign pigmented lesions was greater for lesions 
located on the head and neck. Younger patients, females and those presenting for examinations of 
specific lesions were more likely to exert pressure on doctors and this may suggest that cosmetic 
concerns contribute to high pressure to excise. In this study patients were significantly more likely 
to exert pressure to excise a melanocytic naevi, despite the doctor rating the chance of malignancy 
very low.  
 
Implications for clinical practice 
Diagnosing and managing suspicious skin lesions is a common part of primary care practice and an 
understanding of the pattern and body site distribution can help inform clinical practice. The 
consistent finding that melanoma does occur on intermittently or rarely exposed sites highlights the 
importance of whole-body skin examination. Similarly, we found over one-third of NMSC occurred 
on intermittently sun exposed sites such as the trunk and upper arms and this pattern was more 
pronounced for patients under the age of 50 years. Recent results from a large population-based 
melanoma case-control study found the risk of being diagnosed with thicker melanoma (> 0.75mm) 
was reduced by 14% for patients who had undergone a whole-body clinical examination within the 
three years prior to their melanoma diagnosis and this reduction in risk increased with increasing 
thickness. 
26
  
 
The finding that patients exert a significant amount of pressure to excise apparently benign lesions 
highlights the importance of educating patients about the early signs and symptoms of NMSC and 
melanoma, and should be a routine part of the general practice consultation. Currently in the UK 
core competencies for GPwSI in dermatology include effective communication of these topics. 
27
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Limitations 
While this study was a large prospective study involving 154 primary care doctors some limitations 
should be noted. The study only included excised or biopsied lesions found during a skin 
examination and therefore may not reflect the site distribution of all lesions that present in general 
practice. We relied on the participating doctors to record the body site where the skin lesion was to 
be excised and it is possible there may be some misclassification. However body site was checked 
against the histopathology results, and in the event of a discrepancy, the patient file was examined 
to ensure the correct body site was recorded. While it is possible that there may be some error in the 
interpretation of histopathology by the pathologist, this study was conducted in Queensland, 
Australia, where the incidence of skin cancer is the highest in the world and pathologists have 
extensive experience. Additionally, it is possible that participating doctors may have changed their 
behaviour (Hawthorn effect ) 
28
 in relation to deciding whether or not to excise a lesion during the 
study period.  
 
In conclusion, this study found more than half the lesions excised in general practice in Queensland, 
Australia, were skin cancers which for the most part occurred on the more frequently sun exposed 
body sites. This type of data provides GPs with an indication of the frequency and body site density 
of common skin lesions, thus helping to inform possible diagnoses and management strategies. 
These Australian data provide important benchmark information, against which other international 
studies can be compared to provide additional insight into the possible aetiology of skin cancers and 
pre-malignant lesions excised in general practice.  
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Table 1: Histological distribution of 9,650 excised or biopsied skin lesions according to sex and age group 
 Total  Gender  Age group 
  
n (%) 
 Male 
n (%) 
Female 
n % 
 
p-value
a
 
 < 50 years 
n (%) 
50+ years 
n (%) 
 
p-value
a
 
 Melanoma  152 (1.6)  100 (1.8) 52 (1.3) 0.01  37 (1.5) 115 (1.6) 0.83 
 Squamous cell carcinoma 
b
  1,897 (19.7)  1,139 (20.5) 758 (18.6) 0.02  160 (6.6) 1,737 (24.0) < 0.001 
 Basal cell carcinoma  3,391 (35.1)  2,194 (39.4) 1,197 (29.3) < 0.001  675 (28.0) 2,716 (37.5) < 0.001 
 Actinic keratosis  1,424 (14.8)  787 (14.1) 637 (15.6) 0.09  181 (7.5) 1,243 (17.2) < 0.001 
 Dysplastic naevus  595 (6.2)  325 (5.8) 270 (6.6) 0.07  375 (15.5) 220 (3.0) < 0.001 
 Melanocytic naevus  1,026 (10.6)  458 (8.2) 568 (13.9) < 0.001  738 (30.6) 288 (4.0) < 0.001 
 Other benign pigmented 
c 
 
 TOTAL 
1,165 (12.1) 
9,650 (100) 
 563 (10.1) 
5,566 (100) 
602 (14.7) 
4,084 (100) 
< 0.001  248 (10.3) 
2,414 (100) 
917 (12.7) 
7,236 (100) 
0.008 
a
 p-value reflects the difference in proportions and was adjusted for clustering of doctor and patient; 
b
 includes Bowen’s disease and keratoacanthoma; 
c
 includes seborrhoeic keratosis, lentigo, lichenoid keratosis 
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Table 2: Percent of excised or biopsied skin lesions by histology and body site for males and females 
 
Body site 
 
Melanoma / HMF a  
  
SCC 
  
BCC 
  
Actinic keratosis 
 Dysplastic 
naevi 
 Melanocytic 
naevi 
 Other benign  
pigmented 
 Male 
n  
(%) 
Female 
n 
(%) 
 Male 
n  
(%) 
Female 
n 
(%) 
 Male 
n  
(%) 
Female 
n 
(%) 
 Male 
n  
(%) 
Female 
n 
(%) 
 Male 
n  
(%) 
Female 
n 
(%) 
 Male 
n  
(%) 
Female 
n 
(%) 
 Male 
n  
(%) 
Female 
n 
(%) 
Scalp  
0 
(0.0) 
0 
(0.0) 
 
37 
(3.3) 
3 
(0.4) 
 
24 
(1.1) 
13 
(1.1) 
 
24 
(3.1) 
6 
(0.9) 
 
0 
(0.0) 
0 
(0.0) 
 
13 
(2.8) 
5 
(0.9) 
 
18 
(3.2) 
13 
(0.5) 
Face 
12 
(12.0) 
5 
(9.6) 
 
264 
(23.2) 
205 
(27.0) 
 
567 
(25.8) 
367 
(30.7) 
 
236 
(30.0) 
267 
(41.9) 
 
4 
(1.2) 
1 
(0.4) 
 
54 
(11.8) 
75 
(13.2) 
 
104 
(18.5) 
145 
(24.1) 
Ears 
2 
(2.0) 
0 
(0.0) 
 
71 
(6.2) 
5 
(0.7) 
 
142 
(6.5) 
17 
(1.4) 
 
60 
(7.6) 
8 
(1.3) 
 
2 
(0.6) 
1 
(0.4) 
 
8 
(1.8) 
10 
(1.8) 
 
16 
(2.8) 
5 
(0.8) 
Neck 
7 
(7.0) 
4 
(7.7) 
 
52 
(4.5) 
40 
(5.3) 
 
166 
(7.6) 
79 
(6.6) 
 
58 
(7.4) 
29 
(4.6) 
 
7 
(2.2) 
7 
(2.5) 
 
17 
(3.7) 
23 
(4.0) 
 
35 
(6.2) 
41 
(6.8) 
Upper arm 
21 
(21.0) 
12 
(23.1) 
 
89 
(7.8) 
63 
(8.3) 
 
274 
(12.5) 
192 
(16.0) 
 
52 
(6.6) 
43 
(6.7) 
 
35 
(10.8) 
35 
(13.0) 
 
58 
(12.7) 
75 
(13.2) 
 
62 
(11.0) 
63 
(10.5) 
Forearm 
7 
(7.0) 
5 
(9.6) 
 
156 
(13.7) 
107 
(14.1) 
 
101 
(4.6) 
45 
(3.8) 
 
91 
(11.6) 
56 
(8.8) 
 
3 
(0.9) 
3 
(1.1) 
 
8 
(1.7) 
12 
(2.1) 
 
37 
(6.6) 
49 
(8.1) 
Hand 
0 
(0.0) 
0 
(0.0) 
 
90 
(7.9) 
82 
(10.8) 
 
14 
(0.6) 
17 
(1.4) 
 
61 
(7.7) 
73 
(11.5) 
 
0 
(0.0) 
1 
(0.4) 
 
3 
(0.7) 
9 
(1.6) 
 
11 
(1.9) 
15 
(2.5) 
Thigh 
1 
(1.0) 
4 
(7.7) 
 
50 
(4.4) 
17 
(2.2) 
 
37 
(1.7) 
18 
(1.5) 
 
26 
(3.3) 
9 
(1.4) 
 
20 
(6.2) 
21 
(7.8) 
 
22 
(4.8) 
49 
(8.6) 
 
19 
(3.4) 
24 
(4.0) 
Lower leg/foot 
7 
(7.0) 
9 
(17.3) 
 
206 
(18.1) 
182 
(24.0) 
 
140 
(6.4) 
113 
(9.4) 
 
75 
(9.5) 
92 
(14.4) 
 
14 
(4.3) 
24 
(8.9) 
 
37 
(8.1) 
51 
(9.0) 
 
64 
(11.4) 
67 
(11.1) 
Chest/abdomen 
6 
(6.0) 
2 
(3.9) 
 
63 
(5.5) 
36 
(4.8) 
 
197 
(9.0) 
92 
(7.7) 
 
37 
(4.7) 
31 
(4.9) 
 
56 
(17.2) 
44 
(16.3) 
 
57 
(12.4) 
91 
(16.0) 
 
73 
(13.0) 
99 
(16.4) 
Back/buttock 
37 
(37.0) 
11 
(21.1) 
 
61 
(5.4) 
18 
(2.4) 
 
532 
(24.2) 
244 
(20.4) 
 
67 
(8.5) 
23 
(3.6) 
 
184 
(56.6) 
133 
(49.3) 
 
181 
(39.5) 
168 
(29.6) 
 
124 
(22.0) 
91 
(15.1) 
TOTAL 
100 
 (100.0) 
52 
(100.0) 
 
1,139† 
(100.0) 
758† 
(100.0) 
 
2,194† 
(100.0) 
1,197† 
(100.0) 
 
787†  
(100.0) 
637† 
(100.0) 
 
325 
(100.0) 
270 
(100.0) 
 
458*  
(100.0) 
568* 
(100.0) 
 
563† 
(100.0) 
602 
(100.0)† 
 a 
Hutchinson’s Melanotic Freckle; † P < 0.01; * 0.01 ≤ P < 0.05; P is the test of association between body sites and sex for each histology group and has been adjusted for clustering 
of doctor and patient. 
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Table 3: Number and percent of excised or biopsied skin lesions by histology and body site for ages < 50 years and ≥ 50 years 
 
Body site 
 
Melanoma / HMF a 
  
SCC 
  
BCC 
  
Actinic keratosis 
 Dysplastic 
naevi 
 Melanocytic 
naevi 
 Other benign 
pigmented 
 <50 
n 
(%) 
≥ 50 
n 
(%) 
 <50 
n 
(%) 
≥ 50 
n 
(%) 
 <50 
n 
(%) 
≥ 50 
n 
(%) 
 <50 
n 
(%) 
≥ 50 
n 
(%) 
 <50 
n 
(%) 
≥ 50 
n 
(%) 
 <50 
n 
(%) 
≥ 50 
n 
(%) 
 <50 
n 
(%) 
≥ 50 
n 
(%) 
Scalp  0 
(0.0) 
0 
(0.0) 
 
1 
(0.6) 
39 
(2.3) 
 
12 
(1.8) 
25 
(0.9) 
 
4 
(2.2) 
26 
(2.1) 
 
0 
(0.0) 
0 
(0.0) 
 
13 
(1.8) 
5 
(1.7) 
 
4 
(1.6) 
17 
(1.9) 
Face 3 
(8.1) 
14 
(12.2) 
 
43 
(26.9) 
426 
(24.5) 
 
148 
(21.9) 
786 
(28.9) 
 
69 
(38.1) 
434 
(34.9) 
 
0 
(0.0) 
5 
(2.3) 
 
76 
(10.3) 
53 
(18.4) 
 
59 
(23.8) 
190 
(20.7) 
Ears 0 
(0.0) 
2 
(1.7) 
 
4 
(2.5) 
72 
(4.1) 
 
14 
(2.1) 
145 
(5.3) 
 
11 
(6.1) 
57 
(4.6) 
 
3 
(0.8) 
0 
(0.0) 
 
13 
(1.8) 
5 
(1.7) 
 
4 
(1.6) 
17 
(1.9) 
Neck 2 
(5.4) 
9 
(7.8) 
 
10  
(6.3) 
82 
(4.7) 
 
53 
(7.8) 
192 
(7.1) 
 
5 
(2.8) 
82 
(6.6) 
 
11 
(2.9) 
3 
(1.4) 
 
27 
(3.7) 
13 
(4.5) 
 
16 
(6.4) 
60 
(6.5) 
Upper arm 9 
(24.3) 
24 
(20.9) 
 
14 
(8.7) 
138 
(7.9) 
 
120 
(17.8) 
346 
(12.7) 
 
4 
(2.2) 
91 
(7.3) 
 
39 
(10.4) 
31 
(14.1) 
 
98 
(13.3) 
35 
(12.2) 
 
30 
(12.1) 
95 
(10.4) 
Forearm 2 
(16.7) 
10 
(8.7) 
 
25 
(15.6) 
238 
(13.7) 
 
38 
(5.6) 
108 
(4.0) 
 
20 
(11.0) 
127 
(10.2) 
 
3 
(0.8) 
3 
(1.4) 
 
17 
(2.3) 
3 
(1.0) 
 
15 
(6.1) 
71 
(7.7) 
Hand 0 
(0.0) 
0 
(0.0) 
 
27 
(16.9) 
145 
(8.4) 
 
9 
(1.3) 
22 
(0.8) 
 
30 
(16.6) 
104 
(8.4) 
 
1 
(0.3) 
0 
(0.0) 
 
10 
(1.4) 
2 
(0.7) 
 
7 
(2.8) 
19 
(2.1) 
Thigh 2 
(5.4) 
3 
(2.6) 
 
4 
(2.5) 
63 
(3.6) 
 
12 
(1.8) 
43 
(1.6) 
 
1 
(0.6) 
34 
(2.7) 
 
26 
(6.9) 
15 
(6.8) 
 
55 
(7.4) 
16 
(5.5) 
 
15 
(6.1) 
28 
(3.1) 
Lower leg/foot 4 
(10.8) 
12 
(10.4) 
 
13 
(8.1) 
375 
(21.6) 
 
29 
(4.3) 
224 
(8.3) 
 
9 
(5.0) 
158 
(12.7) 
 
22 
(5.9) 
16 
(7.3) 
 
58 
(7.9) 
30 
(10.4) 
 
22 
(8.9) 
109 
(11.9) 
Chest/abdomen 2 
(5.4) 
6 
(5.2) 
 
13 
(8.1) 
86 
(5.0) 
 
93 
(13.8) 
196 
(7.2) 
 
14 
(7.7) 
54 
(4.3) 
 
68 
(18.1) 
32 
(14.5) 
 
125 
(16.9) 
23 
(8.0) 
 
39 
(15.7) 
133 
(14.5) 
Back/buttock 13 
(35.1) 
35 
(30.4) 
 
6 
(3.8) 
73 
(4.2) 
 
147 
(21.8) 
629 
(23.2) 
 
14 
(7.7) 
76 
(6.1) 
 
202 
(53.9) 
115 
(52.3) 
 
246 
(33.3) 
103 
(35.8) 
 
37 
(14.9) 
178 
(19.4) 
TOTAL 37 
(100.0) 
115 
(100.0) 
 
160 
(100.0) 
1,737 
(100.0) † 
 
675 
(100.0) 
2,716 
(100.0) † 
 
181 
(100.0) 
1,243 
(100.0) † 
 
375 
(100.0) 
220 
(100.0) 
 
738 
(100.0) 
288 
(100.0)* 
 
248 
(100.0) 
917 
(100.0) 
a 
 Hutchinson’s Melanotic Freckle; † P < 0.01; * 0.01 ≤ P < 0.05. P is the test of association between body sites and age group for each histology group and has been adjusted for 
clustering by doctor and patient. 
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Table 4: Factors associated with moderate to high levels of patient pressure to excise benign pigmented skin 
lesions in primary practice 
 % moderate/high 
patient pressure to 
excise 
 
Adjusted odds ratio* 
(95% CI) 
 
 
P-value 
Sex 
 Male (n=1,278) 
 Female (n=1,366) 
 
27.9 
44.4 
 
1.0 
2.07 (1.74-2.45) 
< 0.001 
Age group 
 < 30 years (n=459) 
 30-49 years (n=852) 
 50-69 years (n=934) 
 70+ years (n=399) 
 
40.3 
41.2 
31.0 
34.3 
 
1.18 (0.87-1.59) 
1.28 (1.01-1.66) 
0.87 (0.68-1.11) 
1.0 
0.01 
Body site 
 Head & neck (n=568) 
 Upper limbs (n=455) 
 Lower limbs (n=393) 
 Trunk (n=1,228) 
 
49.7 
32.7 
29.3 
34.0 
 
1.72 (1.40-2.10) 
0.90 (0.72-1.12) 
0.73 (0.59-0.90) 
1.0 
< 0.001 
Histology 
 Dysplastic naevus (n=562) 
 Melanocytic naevus (n=992) 
 Other benign pigmented  (n=1,090) 
 
21.2 
48.1 
33.7 
 
0.58 (0.42-0.79) 
1.72 (1.36-2.18) 
1.0 
< 0.001 
Type of clinical skin examination 
 Whole body (n=1,285) 
 Part body (n=266) 
 Specific lesions (n=1,047) 
 
28.7 
38.4 
45.5 
 
1.0 
1.43 (1.01-2.06) 
2.02 (1.55-2.63) 
< 0.001 
* 
model adjusted for all factors within the table and for clustering by doctor and patient 
 
